COVID-19: What Physicians Need to Know webinar series

Hosted by AMA physician leaders, each installment of this webinar series aims to gain fact-based insights from the nation’s highest-ranking subject matter experts working to protect the health of the public, during the COVID-19 pandemic and beyond.

1. What physicians need to know about tecovirimat (TPOXX) for treatment of monkeypox

   1. AMA and experts from the FDA and CDC discuss about tecovirimat, or TPOXX, for the treatment of monkeypox in infected individuals.

2. Fourth dose boosters and pediatric vaccine update

   1. Susan R. Bailey, MD, immediate past president, AMA, welcomes Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), to discuss a host of hot topics related to the fourth dose booster vaccine and updates on pediatric vaccine safety data.

3. Therapeutics and other treatment options

   1. Experts from the FDA discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. 

4. Booster shots and pediatric vaccines

   1. Dr Marks joins Dr. Bailey to discus,s data and recommendations for Pfizer, Moderna and Janssen booster shots, and the recent authorization of the Pfizer pediatric vaccine for 5- to 11-year-old children.

5. Vaccine misinformation

   Physicians are facing a barrage of patient questions about the COVID-19 vaccine based on extensive rumors, misinformation and disinformation circulating amongst the American public. In the latest "What Physicians Need to Know" webinar, experts discuss vaccine misinformation.

6. Johnson & Johnson COVID-19 vaccine pause

   1. Dr. Marks joins Dr. Bailey to discuss the most up-to-date vaccine information, including the recent paused distribution of the Johnson & Johnson vaccine.

7. Therapeutics for use in COVID-19

   1. Three physician leaders from the FDA to discuss the state of therapeutic clinical trials worldwide, the challenge of obtaining robust therapeutic data and what the future holds based on current research.

8. Vaccine safety and delivery

   1. The AMA welcomes back Dr. Marks to discuss the road ahead now that COVID-19 vaccines are available. 

9. What physicians need to know about vaccine development

   Experts discuss the latest developments on the road to effective COVID-19 vaccines, including a deep dive into the Emergency Use Authorization (EUA) process, specifically how the timeline has been shortened from a matter of years to a matter of months.

10. Project Firstline–CDC’s new national training collaborative for infection control 

    Dr. Bailey and Mike Bell, MD, deputy director of Division of Healthcare Quality Promotion, CDC, kick off Project Firstline, CDC’s new national training collaborative for infection control.

11. CDC Update on COVID-19 vaccine development

    Learn more about the CDC’s role in vaccine review and immunization programs. The purpose of this discussion was to help physicians and the public have a better understanding of the vaccine development process, as well as allocation and distribution of a vaccine, or vaccines, when they become available. 

12. FDA review process for COVID-19 vaccine candidates

    AMA leaders and experts from the FDA provided a comprehensive overview of the COVID-19 vaccine and an inside look at the FDA development and approval process of a vaccine.